Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.

Mu-Hong ChenHui-Ju WuCheng-Ta LiWei-Chen LinShih-Jen TsaiChen-Jee HongPei-Chi TuYa-Mei BaiWei-Chung MaoTung-Ping Su

Published in: Human psychopharmacology (2021)

In this patient population, the commonly used dose of 0.5 mg/kg was sufficient. Additional studies are required to investigate whether repeated infusions of low-dose ketamine may also maintain antidepressant and antisuicidal effects in patients with treatment-resistant double depression.

Keyphrases

low dose
depressive symptoms
pain management
high dose
sleep quality
major depressive disorder
case report
bipolar disorder